Paul J. Sekhri - 17 Feb 2026 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Pres, CEO and Exec Chairperson, Director
Signature
/s/ Paul J. Sekhri
Issuer symbol
VTVT
Transactions as of
17 Feb 2026
Net transactions value
+$5,168,800
Form type
4
Filing time
18 Feb 2026, 16:10:32 UTC
Previous filing
03 Dec 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SEKHRI PAUL J Pres, CEO and Exec Chairperson, Director C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310, HIGH POINT /s/ Paul J. Sekhri 18 Feb 2026 0001264519

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTVT Class A Common Stock Award $5,168,800 +140,000 +56% $36.92 392,212 17 Feb 2026 Class A Common Stock ("Common Stock") 140,000 $36.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest 25% on the first anniversary of the grant date and in quarterly equal installments thereafter.